Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2018-06, Vol.53 (6), p.766-769
Hauptverfasser:	Lamb, Lawrence S., Pillai, Sailesh, Langford, Samantha, Bowersock, Joscelyn, Stasi, Antonio Di, Saad, Ayman
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 631/250/1904 692/699/67/1059/2325 Cell Biology Correspondence Cyclophosphamide Cyclophosphamide - adverse effects Cyclophosphamide - pharmacology Female Graft vs Host Disease - prevention & control Graft-versus-host reaction Hematology Hematopoietic stem cells Humans Internal Medicine Lymphocytes Lymphocytes T Male Medicine Medicine & Public Health Neoplasm Recurrence, Local Peripheral blood Peripheral Blood Stem Cell Transplantation - adverse effects Peripheral Blood Stem Cell Transplantation - methods Prophylaxis Public Health Stem Cells T-Lymphocytes - metabolism Transplantation Transplantation, Haploidentical - adverse effects Transplantation, Haploidentical - methods
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!